You are here: Welcome to the MPKB » Welcome to the MPKB » Non-MP therapies » Corticosteroids
Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Next revisionBoth sides next revision
home:othertreatments:corticosteroids [11.05.2010] – external 127.0.0.1home:othertreatments:corticosteroids [11.05.2010] – paulalbert
Line 5: Line 5:
  
  
-For many physicians, **corticosteroids**, of which glucocorticoids are one kind, are a first-line treatment for a number of diseases, including multiple sclerosis, sarcoidosis, lupus, and rheumatoid arthritis. Corticosteroids suppress the innate immune response, which provides some patients with temporary symptom palliation but also allows chronic pathogens to proliferate. +For many physicians, corticosteroids, of which glucocorticoids are one kind, are a first-line treatment for a number of diseases, including multiple sclerosis, sarcoidosis, lupus, and rheumatoid arthritis. Corticosteroids suppress the innate immune response, which provides some patients with temporary symptom palliation but also allows chronic pathogens to proliferate. 
  
 Research shows that any kind of short-term symptomatic improvement from corticosteroid use does not last, and that over the longer term, use of the drugs can have adverse consequences, including a litany of side effects. For even short periods of time, steroid use can become genuinely addictive. For their own safety, patients on the Marshall Protocol (MP) must [[.:corticosteroids:weaningoffsteroids|wean off]] of them as opposed to discontinuing them outright. Research shows that any kind of short-term symptomatic improvement from corticosteroid use does not last, and that over the longer term, use of the drugs can have adverse consequences, including a litany of side effects. For even short periods of time, steroid use can become genuinely addictive. For their own safety, patients on the Marshall Protocol (MP) must [[.:corticosteroids:weaningoffsteroids|wean off]] of them as opposed to discontinuing them outright.
Line 131: Line 131:
 ^System or function ^ Side effect^^ ^System or function ^ Side effect^^
 |brain    |loss of brain tissue(({{pubmed>long:15882880}})) loss of cognition(({{pubmed>long:12013026}}))     | |brain    |loss of brain tissue(({{pubmed>long:15882880}})) loss of cognition(({{pubmed>long:12013026}}))     |
-|bone   |avascular necrosis of the bone(({{pubmed>long:11850924}}))(({{pubmed>long:10099819}})) osteoporosis(({{pubmed>long:15732231}})) osteonecrosis(({{pubmed>long:18757967}}))| +|bone   |avascular necrosis of the bone(({{pubmed>long:11850924}})) (({{pubmed>long:10099819}})) osteoporosis(({{pubmed>long:15732231}})) osteonecrosis(({{pubmed>long:18757967}}))| 
-|endocrine |suppression of adrenal response(({{pubmed>long:10683005}}))(({{pubmed>long:9623166}})) widespread endocrine dysfunction(({{pubmed>long:2320881}})) Cushing's Syndrome(({{pubmed>long:15850848}})) |+|endocrine |suppression of adrenal response(({{pubmed>long:10683005}})) (({{pubmed>long:9623166}})) widespread endocrine dysfunction(({{pubmed>long:2320881}})) Cushing's Syndrome(({{pubmed>long:15850848}})) |
 |eyes |cataracts(({{pubmed>long:3541262}})) glaucoma(({{pubmed>long:10641955}}))(({{pubmed>long:7701998}})) range of other side effects(({{pubmed>long:11820911}}))    | |eyes |cataracts(({{pubmed>long:3541262}})) glaucoma(({{pubmed>long:10641955}}))(({{pubmed>long:7701998}})) range of other side effects(({{pubmed>long:11820911}}))    |
 |gastrointestinal |gastrointestinal hemorrhage(({{pubmed>long:8927965}})) | |gastrointestinal |gastrointestinal hemorrhage(({{pubmed>long:8927965}})) |
-|muscle  |loss of skeletal muscle(({{pubmed>long: 12843161}})) myopathy (muscle weakness)(({{pubmed>long: 6851197}}))(({{pubmed>long: 9551512}}))(({{pubmed>long: 10939120}}))   |+|muscle  |loss of skeletal muscle(({{pubmed>long: 12843161}})) myopathy (muscle weakness)(({{pubmed>long: 6851197}})) (({{pubmed>long: 9551512}})) (({{pubmed>long: 10939120}}))   |
 |psychological |dementia(({{pubmed>long:15677408}})) | |psychological |dementia(({{pubmed>long:15677408}})) |
 |sexual, female |menstruation disturbance(({{pubmed>long:2815743}}))| |sexual, female |menstruation disturbance(({{pubmed>long:2815743}}))|
-|sexual, male |decrease testosterone(({{pubmed>long: 3083749}}))(({{pubmed>long: 7983641}})) | +|sexual, male |decrease testosterone(({{pubmed>long: 3083749}})) (({{pubmed>long: 7983641}})) | 
-|skin  |skin atrophy(({{pubmed>long: 11393207}}))  |+|skin  |skin atrophy(({{pubmed>long:11393207}}))  |
  
  
home/othertreatments/corticosteroids.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.